E3 PreliminaryPreliminaryPEM not requiredMechanisticPeer-reviewedMachine draft
Study on the active components and mechanism of Suanzaoren decoction in improving cognitive impairment caused by sleep deprivation.
Cheng, Li, Wang, Fei, Li, Zi-Heng et al. · Journal of ethnopharmacology · 2022 · DOI
Quick Summary
This study examined how an ancient Chinese herbal remedy called Suanzaoren Decoction (SZRD) might help improve thinking and memory problems caused by poor sleep. Researchers used computer analysis and laboratory experiments to identify the active ingredients in the herbs and understand how they work in the body, finding that the remedy may work through pathways related to estrogen in the brain.
Why It Matters
Cognitive impairment and sleep disturbance are major symptoms in ME/CFS, and this study offers a potential mechanism-based therapeutic approach grounded in traditional medicine. Understanding how herbal components modulate estrogen signaling and acetylcholinesterase activity could inform novel treatments for post-infectious cognitive dysfunction and sleep-related symptom clusters in ME/CFS.
Observed Findings
- Identified 117 potential bioactive components and 138 intersection targets through network pharmacology analysis.
- Key bioactive components (calycosin, 5-prenylbutein, licochalcone G, glypallichalcone, ZINC189892) showed strong molecular docking affinity to hub genes.
- Hub genes (ACHE, CYP19A1, EGFR, ESR1, ESR2) were enriched in estrogen signaling pathway.
- In vivo experiments demonstrated that SZRD modulates ACHE and CYP19A1 expression through estrogen receptor signaling.
Inferred Conclusions
- SZRD improves cognitive impairment caused by sleep disturbance primarily through activation of estrogen receptor signaling pathways.
- The estrogen signaling pathway is the most important therapeutic target among all enriched pathways in cognitive dysfunction related to sleep deprivation.
- Traditional herbal remedies may offer mechanism-based approaches to managing sleep-related cognitive symptoms through estrogen-dependent neuroprotection.
Remaining Questions
- Does SZRD improve cognitive impairment in human ME/CFS patients with sleep disturbance, and what are the optimal dosing and treatment duration?
- How do sex differences and baseline estrogen levels affect SZRD efficacy in cognitive improvement?
What This Study Does Not Prove
This study does not demonstrate efficacy in human ME/CFS patients or establish that SZRD is clinically effective—only that it may work through estrogen signaling pathways in animal models. The findings are correlative and mechanistic rather than proving causation in disease pathology, and the translation from laboratory findings to clinical benefit in ME/CFS populations remains unestablished.
Tags
Symptom:Cognitive DysfunctionUnrefreshing Sleep
Biomarker:Gene Expression
Method Flag:No ControlsExploratory Only
Metadata
- DOI
- 10.1016/j.jep.2022.115502
- PMID
- 35777606
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →